Abstract:Cardamonin is a chalcone that presents at high content in the seeds of Alpinia katsumadai Hayata. In recent decades, researchers have found that it is not only an edible spice, but also a remarkable herb with a wide range of pharmacological properties. However, its specific metabolic routes in vivo remain unclear while these metabolites may accumulate to exert pharmacological effects. Our study aimed to clarify the metabolic pathways of cardamonin after oral administration to rats. Here, an advanced UHPLC-Q-Exactive Orbitrap MS analytical technique was applied for efficient detection of metabolites in vivo, which especially showed benefits in obtainment of the fragment ions with relatively lower contents. We also established a novel strategy to identify metabolites based on typical fragmentation routes. The results indicated that a total of 40 metabolites could be categorized into 3 types with consideration of the particular structures and characteristic fragment ions. Then, diagnostic product ions (DPIs) of each type were summarized for further screening and identification of metabolites derived from cardamonin. Finally, methylation, demethylation, hydrogenation, hydroxylation, dehydroxylation, glucuronidation and sulfation were confirmed to be the major metabolic pathways in vivo. Our observation extended the metabolic mechanism of cardamonin and could be of great benefits to interpreting the action mechanism of cardamonin in vivo.

What problem does this paper attempt to address?

### Problems Addressed by the Paper This paper encompasses multiple studies, primarily focusing on the field of cardiology, particularly the treatment of chronic heart failure (CHF) and congenital heart disease. #### Part 1: Antioxidant Effects of Carvedilol and Metoprolol in Chronic Heart Failure - **Research Background**: Although it is known that Carvedilol (C) has in vitro antioxidant effects, these effects have not yet been confirmed in human heart failure patients. Additionally, plasma malondialdehyde (TBARS), a marker of lipid peroxidation and oxidative stress, is significantly elevated in heart failure patients and increases with the worsening of the New York Heart Association (NYHA) classification. - **Research Objective**: To evaluate the clinical, hemodynamic, exercise capacity, and antioxidant effects of Carvedilol and Metoprolol (M) in patients with chronic heart failure and to compare the differences between the two. #### Part 2: Effects of Carvedilol on Left Ventricular Function and Remodeling in Patients with Dilated Cardiomyopathy - **Research Background**: To analyze the additional effects of Carvedilol (C) in patients with long-term symptomatic left ventricular dysfunction due to dilated cardiomyopathy (DCM), despite these patients already receiving optimal conventional treatment (including Metoprolol and angiotensin-converting enzyme inhibitors). - **Research Objective**: To evaluate the effects of Carvedilol compared to Metoprolol in improving left ventricular function and remodeling. #### Part 3: Improvement of Diastolic Function and Mitral Regurgitation in Chronic Heart Failure Patients by Carvedilol - **Research Background**: In patients with chronic heart failure, Carvedilol treatment can bring about clinical and hemodynamic improvements. However, data on the effects of Carvedilol on left ventricular diastolic function and mitral regurgitation are insufficient. - **Research Objective**: To determine the specific effects of Carvedilol in improving left ventricular diastolic function and reducing mitral regurgitation. #### Part 4: Surgical Procedures for Congenital Heart Disease - **Research Background**: Various surgical treatment methods for congenital heart disease are explored, including treatment strategies for aortic coarctation with ventricular septal defect, minimally invasive methods for atrial septal defect repair, long-term surgical outcomes of anomalous origin of the left coronary artery from the pulmonary artery, and ventricular septal defect repair in Tetralogy of Fallot with small pulmonary arteries. - **Research Objective**: To propose new surgical strategies to improve treatment outcomes and reduce complications, particularly in the treatment of congenital heart disease in children. Overall, these studies aim to improve the clinical outcomes of patients with chronic heart failure and congenital heart disease through different pharmacological treatments and surgical techniques.

Systematic screening and characterization of cardamonin metabolites using UHPLC-Q-Exactive Orbitrap MS after oral administration to rats

Identification of Metabolites of Crude and Processed Fructus Corni in Rats by Microdialysis Sampling Coupled with Electrospray Ionization Linear Quadrupole Ion Trap Mass Spectrometry.

Characterization of cardamonin metabolism by P450 in different species via HPLC-ESI-ion trap and UPLC-ESI-quadrupole mass spectrometry

Characterization of the Metabolic Fate of Datura Metel Seed Extract and Its Main Constituents in Rats

Metabolite Profiling Analysis of the Tongmai Sini Decoction in Rats after Oral Administration through UHPLC-Q-Exactive-MS/MS

[Identification of Metabolites in Rat Plasma,bile,urine and Feces after Oral Administration of Cinnamomi Cortex Aqueous Extract by UPLC-Qtrap-MS].

A Simple Liquid Chromatography Coupled with Tandem Mass Spectrometry Approach for the Simultaneous Quantification of Thirteen Compounds in Rats Following Oral Administration of Raw and Processed Fructus Xanthii: Application in a Comparative Pharmacokinetic Study

Metabolic Profiling of Icariin in Rat Feces, Urine, Bile and Plasma after Oral Administration Using Ultra-High Performance Liquid Chromatography/quadrupole Time-of-flight Mass Spectrometry

Characterization of Chemical Constituents and Rats Metabolites of an Alkaloidal Extract of Alstonia Scholaris Leaves by Liquid Chromatography Coupled with Mass Spectrometry

Identification and characterization of major alkaloid from Sinomenium acutum stem and their metabolites after oral administration in rat plasma, urine, bile and feces based on UPLC-Q-TOF/MS

Characterization of the herb-derived components in rats following oral administration of Carthamus tinctorius extract by extracting diagnostic fragment ions (DFIs) in the MS(n) chromatograms.

Liquid chromatography-tandem mass spectrometry analysis of protocatechuic aldehyde and its phase I and II metabolites in rat.

Metabolite identification of tanshinol borneol ester in rats by high-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight mass spectrometry

Metabolites of Medicarpin and Their Distributions in Rats

Characterization of chemical constituents and metabolites in rat plasma after oral administration of San Miao Wan by ultra-high performance liquid chromatography tandem Q-Exactive Orbitrap mass spectrometry

Identification of daurisoline metabolites in rats via the UHPLC-Q-exactive orbitrap mass spectrometer

Simultaneous determination and pharmacokinetics of sixteen Angelicae dahurica coumarins in vivo by LC-ESI-MS/MS following oral delivery in rats

In vivo metabolism study of rhubarb decoction in rat using high-performance liquid chromatography with UV photodiode-array and mass-spectrometric detection: a strategy for systematic analysis of metabolites from traditional Chinese medicines in biological samples

An Efficient Integrated Strategy for Comprehensive Metabolite Profiling of Sakurasosaponin from Aegiceras corniculatum in Rats

Metabolites Identification of Two Novel Chemical Constituents From Melia. Toosendan Sieb.et Zucc. in Rats by UPLC/ESI/qTOF-MS Analysis

Metabolic analysis of four phenolic acids in rat by liquid chromatography-tandem mass spectrometry.